Trials / Withdrawn
WithdrawnNCT06207786
Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery
Efficacy of Intranasal Povidone Iodine Swab Versus Oral Antibiotic Prophylaxis to Prevent Surgical Site Infections in Patients Undergoing Mohs Micrographic Surgery
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare surgical site infection rates for patients treated with Mohs micrographic surgery after bilateral nasal swab with povidone iodine versus standard treatment including the use of a standardized oral antibiotic prophylaxis protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Povidone-Iodine Swabs | Undergo nasal swab of both nostrils for 30 seconds into each nostril, allowing two minutes to dry, immediately (e.g. within 30 minutes) prior to performing skin reconstruction. |
| DIAGNOSTIC_TEST | Staphylococcus nasal swab | Undergo a nasal swab to identify patients with preoperative nasal Staphylococcus aureus colonization |
| DRUG | Antibiotic | Receive an oral anti-staphylococcal antibiotic (e.g. oral cephalexin) with standard dosing only if indicated for antibiotic prophylaxis per the Mayo Clinic Dermatologic Surgery Antibiotic Prophylaxis protocol that is currently standard practice for patients undergoing Mohs micrographic surgery (MMS) |
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2029-05-01
- Completion
- 2030-05-01
- First posted
- 2024-01-17
- Last updated
- 2024-11-25
Source: ClinicalTrials.gov record NCT06207786. Inclusion in this directory is not an endorsement.